03:25 PM EDT, 07/25/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We keep our 12-month target price of $275, valuing the shares at 7.5x our '26 operating EPS estimate of $36.55 (cut today by $2.00), versus their five-year average forward multiple of 9x and peers' average of 8x. We up our '25 EPS estimate by $1.11 to $27.70. Q2 EPS of $12.29 versus $12.41 in Q2 '24 topped our $10.17 EPS estimate, as well as the $9.78 consensus view, as improved claim trends and prior year reserve releases offset a 5.1% drop in premiums and produced 26% higher pretax underwriting profits. We lower our operating revenue forecasts, and see a rise of 3% to 6% in '25 and 4% to 8% higher revenues in '26. Barring a surge in catastrophes, we expect underwriting results to remain profitable, but they could erode a bit from the Q2 combined ratio of 75.1% (versus 81.1% a year ago). We see favorable underlying loss trends driving book value growth. Currently trading at less than 1.1x 6/30/25 tangible book value of $223.74 (up 10.4% YTD), we view RNR as undervalued versus peers.